Santen Pharmaceutical Co Ltd - Company Profile
Powered by 
All the sales intelligence you need on Santen Pharmaceutical Co Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Santen Pharmaceutical Co Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Santen Pharmaceutical Co Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Santen Pharmaceutical Co Ltd (Santen) focuses on the research, development, manufacturing, and marketing of pharmaceutical products and medical devices. The company's product portfolio includes prescription ophthalmic products for glaucoma, bacterial conjunctivitis, dry eye, inflammation, cataract, muscae volitantes, diabetic retinopathy, retinal detachment, hyposphagma, myopia, retinal detachment, amblyopia, astigmatism, strabismus, hordeolum, VDT syndrome, and others; over-the-counter products ophthalmic products; anti-allergy ophthalmic products; and medical devices such as intraocular lenses (IOLs) and other ophthalmic products. Santen operates through its group companies located in Asia, Europe and the US. It operates production facilities in Noto, and Shiga, Japan; and Suzhou, China. Santen is headquartered in Osaka-Shi, Osaka, Japan.
Headquarters
Japan
Address
4-20 Ofuka-cho, Grand Front Osaka Tower A, 530-8552
Website
www.santen.com
Telephone
81 6 76648621
No of Employees
3,968
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
4536 (TYO)
Revenue (2025)
$1.9B
-2.8%
(2025 vs 2024)
EPS
XYZ
Net Income (2025)
XYZ
3.1%
(2025 vs 2024)
Market Cap*
$4.0B
Net Profit Margin (2025)
XYZ
6.0%
(2025 vs 2024)
* As of and is in US$
Santen Pharmaceutical Co Ltd premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Prescription Ophthalmic Products | Hyalein |
| Over-the-Counter Products | Eylea |
| Medical Devices | Carvit |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | Contracts/Agreements | In July, the company signed an agreement with KYORIN Pharmaceutical Co. for joint marketing in Japan of Alesion eyelid cream 0.5%. |
| 2026 | Contracts/Agreements | In April, Santen China signed a distribution and promotion agreement with AbbVie to market five glaucoma eye drop products in the Chinese mainland. |
| 2026 | New Products/Services | In January, the company announced the launch of Aflibercept kit for IVT injection. |
Competitor Comparison
| Key Parameters | Santen Pharmaceutical Co Ltd | Astellas Pharma Inc | Daiichi Sankyo Co Ltd | Chugai Pharmaceutical Co Ltd | Hoya Corp |
|---|---|---|---|---|---|
| Headquarters | Japan | Japan | Japan | Japan | Japan |
| City | Osaka | Chuo-Ku | Chuo-Ku | Chuo-Ku | Shinjuku-Ku |
| State/Province | Osaka | Tokyo | Tokyo | Tokyo | Tokyo |
| No. of Employees | 3,968 | 13,643 | 20,171 | 7,872 | 37,752 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Takeshi Ito | Director; President; Chief Executive Officer | Executive Board | 2022 | 66 |
| Rie Nakajima | Executive Officer; Director; Chief Operating Officer | Executive Board | 2023 | 48 |
| Kazuo Koshiji | Chief Financial Officer | Senior Management | 2012 | - |
| Daisuke Nakata | Chief Information Officer; Chief Digital Officer | Senior Management | 2025 | - |
| Mika Masunari | Chief Risk Officer; Chief Compliance Officer; General Counsel | Senior Management | 2025 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer